Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
69,166.29
(
0.40%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 91
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: investorgold2002 post# 121388

Thursday, 06/09/2011 8:32:27 PM

Thursday, June 09, 2011 8:32:27 PM

Post# of 257268 

It;s interesting that fondaparinux received a priority review(dont know the basis?) by FDA. One would think copaxone being such a heavily used product, would also necessitate a priority review.



Priority reviews are part of the PDUFA act that applies to NDA/BLAs, but not ANDAs.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today